Jörg Reinhardt Novartis Chair of the Board of DirectorsJörg Reinhardt Novartis Chair of the Board of Directors

Basel, Switzerland — Novartis shareholders Tuesday approved all resolutions proposed at the Annual General Meeting, including a dividend increase, re-election of Board members, reduction of share capital, approval of non-financial reports, and compensation votes.

Shareholders also re-elected Jörg Reinhardt as Chair of the Board of Directors, and all current members of the Board, for one year.

The meeting had a 53.65% shareholder representation. KPMG AG was elected as the auditor for the upcoming financial year. Novartis is an innovative medicines company aiming to improve lives globally.

Rwanda Leads With 61.3% Female Representation in Parliament, Germay 35.3% Women

By Lisa Luckas

Lisa Luckas is a Sr. Business News Editor at Nobot.News.

Leave a Reply

Your email address will not be published. Required fields are marked *

GDPR Cookie Consent with Real Cookie Banner